RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 995-1004

  Tarnowski, Maciej ^a,b   Schneider, Gabriela ^a   Amann, Gabriele ^c   Clark, Geoffrey ^a   Houghton, Peter ^d   Barr, Frederic G ^e   Kenner, Lukas ^c   Ratajczak, Mariusz Z ^a,b   Kucia, Magda ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d World Children's Cancer Center   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Metastasis; Ras; RasGRF1; Rhabdomyosarcoma

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; SHORT HAIRPIN RNA; SOMATOMEDIN B; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RHABDOMYOSARCOMA; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; ENZYME INHIBITORS; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR II; METHIONINE; MICE; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOPODIA; RAS-GRF1; RHABDOMYOSARCOMA, ALVEOLAR; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84864982660     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1536     Document Type: Article

References (50)

1. Barr FG, Galili N, Holick J, Biegel JA, Rovera G and Emanuel BS: Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 3: 113-117, 1993. (Pubitemid 23079791)
2. Collins MH, Zhao H, Womer RB and Barr FG: Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. Med Pediatr Oncol 37: 83-89, 2001. (Pubitemid 32738067)
3. Hazelton BJ, Houghton JA, Parham DM, et al: Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res 47: 4501-4507, 1987. (Pubitemid 17128155)
4. Kelly KM, Womer RB and Barr FG: PAX3-FKHR and PAX7-FKHR gene fusions in rhabdomyosarcoma. J Pediatr Hematol Oncol 20: 517-518, 1998. (Pubitemid 29133216)
5. Sandberg AA, Stone JF, Czarnecki L and Cohen JD: Hematologic masquerade of rhabdomyosarcoma. Am J Hematol 68: 51-57, 2001. (Pubitemid 32738719)
6. Sharp R, Recio JA, Jhappan C, et al: Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat Med 8: 1276-1280, 2002. (Pubitemid 35373560)
7. Gordon T, McManus A, Anderson J, et al: Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study. Med Pediatr Oncol 36: 259-267, 2001. (Pubitemid 32121310)
8. Charytonowicz E, Cordon-Cardo C, Matushansky I and Ziman M: Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279: 126-136, 2009.
9. Hahn H, Wojnowski L, Specht K, et al: Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J Biol Chem 275: 28341-28344, 2000.
10. Makawita S, Ho M, Durbin AD, Thorner PS, Malkin D and Somers GR: Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors. Pediatr Dev Pathol 12: 127-135, 2009.
11. Rikhof B, De Jong S, Suurmeijer AJ, Meijer C and van der Graaf WT: The insulin-like growth factor system and sarcomas. J Pathol 217: 469-482, 2009.
12. Wang W, Kumar P, Epstein J, Helman L, Moore JV and Kumar S: Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Cancer Res 58: 4426-4433, 1998. (Pubitemid 28450047)
13. Naini S, Etheridge KT, Adam SJ, et al: Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma. Cancer Res 68: 9583-9588, 2008.
14. Innocenti M, Zippel R, Brambilla R and Sturani E: CDC25(Mm)/Ras-GRF1 regulates both Ras and Rac signaling pathways. FEBS Lett 460: 357-362, 1999. (Pubitemid 29495969)
15. Lavagni P, Indrigo M, Colombo G, et al: Identification of novel RasGRF1 interacting partners by large-scale proteomic analysis. J Mol Neurosci 37: 212-224, 2009.
16. Rossman KL, Der CJ and Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180, 2005. (Pubitemid 40215811)
17. Langenau DM, Keefe MD, Storer NY, et al: Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 21: 1382-1395, 2007. (Pubitemid 46871041)
18. Shome D, Honavar SG, Reddy VA and Vemuganti GK: Orbital embryonal rhabdomyosarcoma in association with neurofibromatosis type 1. Ophthal Plast Reconstr Surg 23: 147-148, 2007. (Pubitemid 46596609)
19. Yang P, Grufferman S, Khoury MJ, et al: Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects. Genet Epidemiol 12: 467-474, 1995.
20. Jung A, Bechthold S, Pfluger T, Renner C and Ehrt O: Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 25: 330-332, 2003. (Pubitemid 36506224)
21. Khan S, McDowell H, Upadhyaya M and Fryer A: Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet 32: 743-745, 1995.
22. Gripp KW, Scott CI Jr, Nicholson L, et al: Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol. Am J Med Genet 108: 80-87, 2002.
23. Feingold M: Costello syndrome and rhabdomyosarcoma. J Med Genet 36: 582-583, 1999.
24. O'Neal JP, Ramdas J, Wood WE and Pellitteri PK: Parameningeal rhabdomyosarcoma in a patient with Costello syndrome. J Pediatr Hematol Oncol 26: 389-392, 2004. (Pubitemid 38747732)
25. Tidyman WE and Rauen KA: The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19: 230-236, 2009.
26. Hettmer S and Wagers AJ: Muscling in: uncovering the origins of rhabdomyosarcoma. Nat Med 16: 171-173, 2010.
27. Shin DM, Zuba-Surma EK, Wu W, et al: Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia 23: 2042-2051, 2009.
28. Stratton MR, Fisher C, Gusterson BA and Cooper CS: Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 49: 6324-6327, 1989. (Pubitemid 20000931)
29. Ren YX, Finckenstein FG, Abdueva DA, et al: Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res 68: 6587-6597, 2008.
30. Libura J, Drukala J, Majka M, et al: CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100: 2597-2606, 2002.
31. Jankowski K, Kucia M, Wysoczynski M, et al: Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 63: 7926-7935, 2003. (Pubitemid 37466729)
32. Grymula K, Tarnowski M, Wysoczynski M, et al: Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 127: 2554-2568, 2010.
33. Tarnowski M, Grymula K, Reca R, et al: Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res 8: 1-14, 2010.
34. + cells in adult tissues. Stem Cell Rev 6: 307-316, 2010.
35. Casola S, Pedone PV, Cavazzana AO, et al: Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Oncogene 14: 1503-1510, 1997. (Pubitemid 27182440)
36. Anderson J, Gordon A, McManus A, Shipley J and Pritchard-Jones K: Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1: 340-348, 1999.
37. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K and Sapienza C: A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 86: 7480-7484, 1989. (Pubitemid 19254480)
38. Zhan S, Shapiro DN and Helman LJ: Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 94: 445-448, 1994. (Pubitemid 24218124)
39. Taichman RS, Wang Z, Shiozawa Y, et al: Prospective identification and skeletal localization of cells capable of multilineage differentiation in vivo. Stem Cells Dev 19: 1557-1570, 2010.
40. De la Puente A, Hall J, Wu YZ, et al: Structural characterization of Rasgrf1 and a novel linked imprinted locus. Gene 291: 287-297, 2002. (Pubitemid 34722397)
41. Yoon B, Herman H, Hu B, et al: Rasgrf1 imprinting is regulated by a CTCF-dependent methylation-sensitive enhancer blocker. Mol Cell Biol 25: 11184-11190, 2005. (Pubitemid 41747157)
42. Yoon BJ, Herman H, Sikora A, Smith LT, Plass C and Soloway PD: Regulation of DNA methylation of Rasgrf1. Nat Genet 30: 92-96, 2002.
43. Martegani E, Vanoni M, Zippel R, et al: Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. EMBO J 11: 2151-2157, 1992.
44. Buchsbaum R, Telliez JB, Goonesekera S and Feig LA: The N-terminal pleckstrin, coiled-coil, and IQ domains of the exchange factor Ras-GRF act cooperatively to facilitate activation by calcium. Mol Cell Biol 16: 4888-4896, 1996. (Pubitemid 26272144)
45. Chevallier-Multon MC, Schweighoffer F, Barlat I, et al: Saccharomyces cerevisiae CDC25 (1028-1589) is a guanine nucleotide releasing factor for mammalian ras proteins and is oncogenic in NIH3T3 cells. J Biol Chem 268: 11113-11118, 1993. (Pubitemid 23162300)
46. Leaner VD, Donninger H, Ellis CA, Clark GJ and Birrer MJ: p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. Mol Cell Biol 25: 3324-3337, 2005. (Pubitemid 40464332)
47. Font de Mora J, Esteban LM, Burks DJ, et al: Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 22: 3039-3049, 2003. (Pubitemid 36758624)
48. Guerrero C, Rojas JM, Chedid M, et al: Expression of alternative forms of Ras exchange factors GRF and SOS1 in different human tissues and cell lines. Oncogene 12: 1097-1107, 1996. (Pubitemid 26104453)
49. Forlani G, Baldassa S, Lavagni P, Sturani E and Zippel R: The guanine nucleotide exchange factor RasGRF1 directly binds microtubules via DHPH2-mediated interaction. FEBS J 273: 2127-2138, 2006.
50. Arozarena I, Matallanas D, Berciano MT, et al: Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors. Mol Cell Biol 24: 1516-1530, 2004. (Pubitemid 38167075)